Eugene Schneider
CIK 1838539 · EVP, Chf Clinical Develop Ofcr · last filed 2026-03-23
Eugene Schneider is an EVP, Chf Clinical Develop Ofcr who has filed 26 SEC Form 4 insider transactions across 1 company since 2021. The most recent filing shows the insider sold $412.5K of IONS on Mar 23, 2026. Across all open-market trades the lifetime net is −$5.9M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $4.7M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$4.68M
1
26
-$5.94M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| IONS | EVP, Chf Clinical Develop Ofcr | 63,890 | $73.28 | $4.68M | -$5.94M | 26 | 2026-03-23 |
Recent Filings
26 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-03-23 | IONS | Sell (S) | −5,812 | -$412.5K | EDGAR |
| 2026-02-02 | IONS | Mixed | +5,812 | -$515.6K | EDGAR |
| 2026-01-20 | IONS | Mixed | +12,383 | -$703.1K | EDGAR |
| 2026-01-06 | IONS | Grant (A) | — | $0 | EDGAR |
| 2025-09-04 | IONS | Mixed | — | -$138.4K | EDGAR |
| 2025-08-05 | IONS | Sell (S) | −9,549 | -$408.7K | EDGAR |
| 2025-02-03 | IONS | Mixed | +2,548 | -$47.8K | EDGAR |
| 2025-01-17 | IONS | Mixed | +10,849 | -$213.9K | EDGAR |
| 2025-01-06 | IONS | Grant (A) | — | $0 | EDGAR |
| 2024-09-04 | IONS | Sell (S) | −2,106 | -$104.4K | EDGAR |